Peptide Industry beginner
Peptide Investment
Venture capital, M&A, and public market investment trends in peptide therapeutics.
By Encyclopeptide Editorial | 1 min read
investment venture-capital funding industry
Overview
Investment in peptide therapeutics has surged, driven by clinical successes in metabolic diseases and expanding applications.
Investment Trends
- VC funding: Record levels for peptide-focused biotechs
- M&A activity: Large pharma acquiring peptide companies
- IPO market: Peptide companies accessing public markets
- Partnerships: Pharma-biotech collaboration deals
Notable Deals
- Novo Nordisk’s investments in oral peptide technology
- Eli Lilly’s tirzepatide commercial success
- Bicycle Therapeutics’ platform partnerships
- Protagonist’s collaboration with Janssen
Investment Themes
Oral delivery, AI-designed peptides, and peptide drug conjugates are attracting the most investor interest.
References
- Source: ENCP Peptide Database
- Category: Peptide Industry
Test Your Knowledge
Reinforce what you learned about Peptide Investment with interactive quizzes on Wikipept.
Take a Quiz on Wikipept